Clinical trials: Meningioma

Meningioma

Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma

• Completed
• Age: 18 years and older
• Phase 3
• Results posted

This Phase 3 open-label single-arm study is designed to investigate the safety, diagnostic performance, and clinical usefulness of Gleolan for the real time detection and visualization of meningiomas during tumor resection…

Trial name

MEN-301 (NCT04305470)

Testing

Gleolan

Where

17 sites in United States, Austria and 1 more

Volunteers

108 people

Sponsor

NX Development Corp